Beranda › Psoriasis
Uji klinis Psoriasis yang merekrut di AS
39 studi untuk Psoriasis merekrut peserta di lokasi di seluruh Amerika Serikat.
Kota dengan studi terbanyak
- Trenton, NJ7 studi
- Newton, MA6 studi
- Cleveland, OH6 studi
- New York City, NY5 studi
- Fremont, CA5 studi
- San Antonio, TX5 studi
- Philadelphia, PA5 studi
- Miami, FL4 studi
- Huntington Beach, CA4 studi
- Birmingham, AL4 studi
- Rochester, NY3 studi
- Houston, TX3 studi
- Indianapolis, IN3 studi
- San Diego, CA3 studi
- Tampa, FL3 studi
- Los Angeles, CA3 studi
- Hialeah, FL3 studi
- Sacramento, CA3 studi
- Columbus, OH3 studi
- Dallas, TX3 studi
Berdasarkan negara bagian
- Alabama4 studi
- Arizona3 studi
- California14 studi
- Florida8 studi
- Georgia4 studi
- Indiana4 studi
- Kentucky4 studi
- Maryland4 studi
- Massachusetts9 studi
- Michigan4 studi
- New Jersey9 studi
- New York8 studi
- North Carolina3 studi
- Ohio9 studi
- Pennsylvania6 studi
- Texas8 studi
- Washington3 studi
Studi yang baru diperbarui
Teks studi resmi (Bahasa Inggris)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
Menerima pesertaFase 2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT07013201A Study to Assess Deucravacitinib Safety in Pregnancy
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Semua usia · Wanita · Diperbarui 1 Okt 2026 · NCT07017699A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Menerima pesertaFase 3
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT07362017Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 22 Sep 2026 · NCT04864886The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Menerima pesertaFase 4Sukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 9 Sep 2026 · NCT07487831Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
Menerima peserta
Usia 18 hingga 94 · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06399432A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 4 Sep 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Menerima pesertaFase 3
Usia 12 hingga 17 · Semua jenis kelamin · Diperbarui 3 Sep 2026 · NCT06979453A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Menerima pesertaFase 4
Usia 18 ke atas · Wanita · Diperbarui 28 Agu 2026 · NCT07654751The CorEvitas Psoriasis (PSO) Registry
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT02707341A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 27 Agu 2026 · NCT07219420PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07615712CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT06100991PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 26 Agu 2026 · NCT07648602The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Jul 2026 · NCT07390487Skin Microbial Ecology in Atopic Dermatitis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 13 ke atas · Semua jenis kelamin · Diperbarui 14 Jul 2026 · NCT04170244A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Menerima pesertaFase 2
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 9 Jul 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 16 Jun 2026 · NCT06574178Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Menerima pesertaStudi observasional
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT04751396Regulation of Inflammatory Genes in Psoriasis
Menerima pesertaStudi observasionalSukarelawan sehat diterima
Usia 19 hingga 99 · Semua jenis kelamin · Diperbarui 6 Apr 2026 · NCT03125655Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Menerima pesertaFase 4
Usia 18 hingga 89 · Semua jenis kelamin · Diperbarui 2 Apr 2026 · NCT05270733Multi-Center PAMPA Study
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 30 Mar 2026 · NCT05004727A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Mar 2026 · NCT07471048Dari ClinicalTrials.gov, data diambil 2 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.